28 Sep 2018
In October 2017, the AMA responded to MBS Review Taskforce Clinical Committee reports that were released as part of Round Two consultations, in particular, elements of the reports on cardiac services, endocrinology and pathology endocrine tests, which add to the growing concerns around the MBS review process, governance and outcomes.
AMA Submission to the Department of Health Consultation: Colonoscopy - Government response to MBS Review
01 Aug 2018
In May 2018, the AMA responded to the MBS Review Taskforce’s Gastroenterology Clinical Committee consultation, on proposed changes to colonoscopy MBS items.
The Department of Health has advised that the MBS items for colonoscopy 32090 and 32093 will be replaced by 20 new MBS items that better describe the indications for initial colonoscopy and ensure appropriate surveillance intervals of patients at increased risk of developing colorectal cancer. Also, claiming restrictions will apply with other colonoscopy services (same day, same patient, same practitioner).
AMA Submission to the Department of Health Consultation: Spinal Surgery - Government response to MBS Review
01 Aug 2018
The review of Spinal Surgery MBS items pre-dated the MBS Review Taskforce and the AMA was represented on the review. This work was later absorbed by the MBS Review Spinal Services Clinical Committee (SSCC), who released draft recommendations for public consultation between 7 June and 21 July 2017.
The AMA did not oppose the SSCC’s final MBS recommendations released in January 2018. The AMA acknowledged the overall outcome of the changes would be a simplified, modern schedule for medical practitioners performing these specialised spinal services.
AMA Submission to the Department of Health Consultation: Oncology - Government response to MBS Review
31 Jul 2018
The Department of Health’s MBS Taskforce is undertaking a program of work to consider how the more than 5,700 items on the MBS can be aligned with contemporary clinical evidence and practice in order to improve health outcomes for patients. The Taskforce has established Clinical Committees and Working Groups to undertake clinical reviews of MBS items.